This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Vyvanse (2015-12-23)

Starting date:
December 23, 2015
Posting date:
December 31, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-56514

Affected Products

Vyvanse

Reason

Some labels were found missing on product bottles from these lots.

Depth of distribution

Wholesalers across Canada

Affected products

Vyvanse

DIN, NPN, DIN-HIM
DIN 02322951
Dosage form

Capsule

Strength

Lisdexamfetamine Dimesylate 30mg

Lot or serial number
  • AD8671B
  • AD8672B
Companies
Recalling Firm
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
Marketing Authorization Holder
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA

Date modified: